E company news, Qingdao Baheal Medical Inc(301015) (301015) announced on February 13 that the company signed a marketing service agreement with Shanghai Yizhong Pharmaceutical Co.Ltd(688091) (688091), and Shanghai Yizhong Pharmaceutical Co.Ltd(688091) entrusted Qingdao Baheal Medical Inc(301015) to provide product promotion services for the agreement products (i.e. "paclitaxel polymer micelles for injection") within the scope of cooperation. The agreement is valid until December 31, 2025. This signing expands the commercial cooperation of the company's products in the field of anti-cancer and anti-tumor, enriches the brand matrix of the company's operation, and is conducive to improving the company's revenue scale and sustainable profitability.